IN2012DN06279A - - Google Patents
Info
- Publication number
- IN2012DN06279A IN2012DN06279A IN6279DEN2012A IN2012DN06279A IN 2012DN06279 A IN2012DN06279 A IN 2012DN06279A IN 6279DEN2012 A IN6279DEN2012 A IN 6279DEN2012A IN 2012DN06279 A IN2012DN06279 A IN 2012DN06279A
- Authority
- IN
- India
- Prior art keywords
- rosacea
- receptor
- cxcl5
- chemokines
- interleukin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28211309P | 2009-12-17 | 2009-12-17 | |
PCT/EP2010/069896 WO2011073321A1 (fr) | 2009-12-17 | 2010-12-16 | Marqueurs et procédé de diagnostic de la rosacée |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN06279A true IN2012DN06279A (fr) | 2015-09-25 |
Family
ID=43417037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6279DEN2012 IN2012DN06279A (fr) | 2009-12-17 | 2010-12-16 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20130017969A1 (fr) |
EP (1) | EP2513328A1 (fr) |
JP (1) | JP2013514070A (fr) |
KR (1) | KR20120115321A (fr) |
CN (1) | CN102762742A (fr) |
AU (1) | AU2010332876A1 (fr) |
BR (1) | BR112012014678A2 (fr) |
CA (1) | CA2783693A1 (fr) |
IN (1) | IN2012DN06279A (fr) |
MX (1) | MX2012006623A (fr) |
RU (1) | RU2012130069A (fr) |
WO (1) | WO2011073321A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10370714B2 (en) | 2011-06-27 | 2019-08-06 | Galderma Research & Development | Th-17 differentiation markers for rosacea and uses thereof |
EP2723892A2 (fr) * | 2011-06-27 | 2014-04-30 | Galderma Research & Development | Nouveaux marqueurs de différenciationth7 pour la rosacée et utilisations de ces derniers |
CA2852160A1 (fr) * | 2011-10-28 | 2013-05-02 | Galderma Research & Development | Nouveaux marqueurs d'infiltrat leucocytaire de rosacee et utilisations de ceux-ci |
EP2791354B1 (fr) | 2011-12-16 | 2017-06-14 | Galderma Research & Development | Procédé pour le diagnostic de l'acné rosacée |
US9860241B2 (en) * | 2014-04-15 | 2018-01-02 | Level 3 Communications, Llc | Device registration, authentication, and authorization system and method |
KR101712747B1 (ko) | 2015-11-06 | 2017-03-07 | 가톨릭대학교 산학협력단 | 유파틸린을 유효성분으로 포함하는 피부질환 예방 또는 치료용 조성물 |
CN106119348B (zh) * | 2016-06-27 | 2018-02-23 | 中南大学湘雅医院 | 一种以非编码lnc‑CXCL1及编码基因cxcl1组合为检测或诊断筛查标志物的重症肌无力检测试剂盒及应用 |
KR102216941B1 (ko) * | 2020-08-12 | 2021-02-18 | 주식회사 큐티스의생명연구센터 | 마이크로니들 패치를 포함하는 최소 침습적 홍조성 민감피부 평가 키트 및 홍조성 민감피부 평가를 위한 바이오마커 |
US20230304091A1 (en) * | 2020-08-10 | 2023-09-28 | Cutis Biomedical Research Center | Minimally invasive kit for diagnosing skin condition, comprising microneedle patch |
CN113462770B (zh) * | 2021-08-25 | 2023-03-31 | 中国医科大学附属第一医院 | 趋化因子作为玫瑰痤疮诊断的分子标志物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090118141A1 (en) * | 2005-05-04 | 2009-05-07 | The Regents Of The University Of California | Methods of oligosaccharide profiling for the detection of ocular rosacea |
EP2124058B1 (fr) * | 2006-01-05 | 2014-03-05 | Galderma Research & Development | Méthode de diagnostic basée sur des biomarqueurs de lésions acnéiques et procédé de criblage de leurs modulateurs |
EP2069377A4 (fr) * | 2006-09-27 | 2009-11-11 | Univ California | Procédés et compositions pour le traitement de maladies et de troubles de la peau |
EP2212442A1 (fr) | 2007-10-26 | 2010-08-04 | Galderma Research & Development | Procédé non invasif pour études pharmaco-génomiques de maladies inflammatoires cutanées et leur procédé de diagnostic |
FR2923610B1 (fr) | 2007-11-14 | 2009-11-27 | Galderma Res & Dev | Methode non-invasive de recueil de donnees biologiques pour l'etablissement d'un diagnostic d'une pathologie cutanee. |
-
2010
- 2010-12-16 IN IN6279DEN2012 patent/IN2012DN06279A/en unknown
- 2010-12-16 US US13/516,834 patent/US20130017969A1/en not_active Abandoned
- 2010-12-16 EP EP10788092A patent/EP2513328A1/fr not_active Withdrawn
- 2010-12-16 KR KR1020127018566A patent/KR20120115321A/ko not_active Application Discontinuation
- 2010-12-16 JP JP2012543751A patent/JP2013514070A/ja active Pending
- 2010-12-16 RU RU2012130069/10A patent/RU2012130069A/ru not_active Application Discontinuation
- 2010-12-16 CA CA2783693A patent/CA2783693A1/fr not_active Abandoned
- 2010-12-16 MX MX2012006623A patent/MX2012006623A/es not_active Application Discontinuation
- 2010-12-16 CN CN2010800573982A patent/CN102762742A/zh active Pending
- 2010-12-16 BR BR112012014678A patent/BR112012014678A2/pt not_active IP Right Cessation
- 2010-12-16 WO PCT/EP2010/069896 patent/WO2011073321A1/fr active Application Filing
- 2010-12-16 AU AU2010332876A patent/AU2010332876A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2013514070A (ja) | 2013-04-25 |
CN102762742A (zh) | 2012-10-31 |
EP2513328A1 (fr) | 2012-10-24 |
MX2012006623A (es) | 2012-11-30 |
AU2010332876A1 (en) | 2012-07-12 |
BR112012014678A2 (pt) | 2016-04-05 |
US20130017969A1 (en) | 2013-01-17 |
CA2783693A1 (fr) | 2011-06-23 |
KR20120115321A (ko) | 2012-10-17 |
WO2011073321A1 (fr) | 2011-06-23 |
RU2012130069A (ru) | 2014-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN06279A (fr) | ||
MX2010003139A (es) | Agentes terapeuticos para la enfermedad de injerto contra hospedero que comprenden un inhibidor del receptor de interleucina 6 como ingrediente activo. | |
MX2019013922A (es) | Inhibidores novedosos de map4k1. | |
MX352614B (es) | Nuevos agentes anti-inflamatorios. | |
NZ742819A (en) | Inhibitors of cxcr2 | |
UA103634C2 (en) | Azaindazole compounds as ccr1 receptor antagonists | |
EA201171074A1 (ru) | Цитотоксические конъюгаты с соединением, связывающим рецептор нейропептида y | |
EA200970051A1 (ru) | Антагонист рецептора il-8 | |
ECSP11011433A (es) | Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides | |
CR10379A (es) | Composiones farmaceuticas de antagonistas del anticuerpo anti-cd40. | |
EA201201541A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛАМИНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К M3 МУСКАРИНОВОМУ РЕЦЕПТОРУ | |
CL2014001452A1 (es) | Compuestos derivados de dihidro-benzo-oxacina y dihidro-pirido-oxacina; composicion farmaceutica; metodo para modular la actividad de enzimas pi3k; metodo para el tratamiento; y uso para el tratamiento de artritis reumatoide, pénfigo vulgar, esclerosis multiple, miastenia grave, alergia y malaria, entre otras enfermedades. | |
WO2011154139A3 (fr) | Marqueurs d'expression génique pour la prédiction d'une réponse à un traitement par un médicament anticorps monoclonal inhibant le récepteur de l'interleukine-6 | |
SG154441A1 (en) | Treatment of demyelinating disorders | |
WO2010044543A3 (fr) | Composé hétérocyclique utilisé comme inhibiteur de la protéine kinase | |
WO2012103360A3 (fr) | Compositions de wnt et procédés d'utilisation de celles-ci | |
WO2007108936A3 (fr) | Azacyclylamines avec substitution n en tant qu'antagonistes de l'histamine-3 | |
WO2010112458A8 (fr) | Composition et procédés d'utilisation d'anticorps thérapeutiques spécifiques du sous-motif bêta-1 des récepteurs d'il-12 | |
MX2010006089A (es) | Metodos de tratamiento de enfermedad pulmonar obstructiva cronica. | |
WO2007136668A3 (fr) | N-benzoyle et n-benzylpyrrolidin-3-ylamines comme antagonistes de l'histamine-3 | |
WO2007015157A3 (fr) | Nouvelles utilisations de composes d'agonistes du recepteur de mc4 | |
MX2011012669A (es) | Nuevos agonistas del receptor de glucocorticoides. | |
UA102231C2 (ru) | Применение фипронила для увеличения урожайности пшеницы и способ обработки пшеницы | |
EA201001842A1 (ru) | Новые соединения, обладающие активностью антагонистов мускариновых рецепторов | |
TNSN07462A1 (en) | Ampa receptor potentiators |